| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |